COVID-19 Vaccine | Fortune

Skip to Content

NEW

A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily.

SIGN IN

Newsletters
Bitcoin and tech stocks climb as bond yields tumble
By
Bernhard Warner
March 22, 2021
Health
AstraZeneca COVID-19 vaccine was 79% effective in U.S. trial, paving way for potential approval
By
Bloomberg
March 22, 2021
Health
How rapid COVID vaccine rollouts ‘backfired’ in some U.S. states
By
Carla K. Johnson,
Nicky Forster,
and others
March 22, 2021
International
China has secured 100 million doses of BioNTech’s vaccine. Why hasn’t it approved the jab yet?
By
Grady McGregor
March 20, 2021
Health
Pregnant women aren’t typically included in clinical trials, but that’s changing with COVID
By
Sy Mukherjee
March 19, 2021
International
‘Virus metrics are getting uglier’: Why COVID-ravaged Europe is locking down again
By
Bernhard Warner
March 19, 2021
Health
European stocks slip as coronavirus variants force retreat into lockdown
By
David Meyer
March 19, 2021
Commentary
The choice for rich nations: Help vaccinate the developing world, or face a prolonged pandemic
By
Rajiv J. Shah
March 19, 2021
International
Like it or not, vaccine passports are coming soon to an airport near you
By
Grady McGregor
March 19, 2021
Health
Online sign-ups made the U.S. vaccine rollout less fair. Here’s how to fix them
By
David Z. Morris
March 18, 2021
Health
AstraZeneca’s COVID vaccine gets all-clear from EU health agency following blood clot uproar
By
Richard Bravo
and
Bloomberg
March 18, 2021
Health
28.5% of American adults have gotten a COVID vaccine: How each U.S state is doing
By
Erika Fry
and
Nicolas Rapp
March 17, 2021
International
COVID certificates for travelers seen as a lifeline for Europe’s ravaged tourism sector
By
Nikos Chrysoloras,
Siddharth Philip,
and others
March 17, 2021
International
China promises to ease restrictions for visitors—but only if they get Chinese vaccines
By
Grady McGregor
March 17, 2021

1 - 14 of 196 results

1 - 14 of 196 results

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Personal Information | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.